-
A Randomized Sham-Controlled Trial of Accelerated Intermittent Theta Burst Stimulation for Treatment Resistant Depression
https://braincanada.ca/funded-grants/a-randomized-sham-controlled-trial-of-accelerated-intermittent-theta-burst-stimulation-for-treatment-resistant-depressionBy 2050, over 1 million Canadians will suffer from depression; many of whom will not respond to traditional antidepressant medication, known to as treatment resistant depression (TRD). Project Overview By 2050, over 1 million Canadians will suffer from depression; many of whom will not respond to...
-
A research platform to study animal and human cellular models of neurological disorders
https://braincanada.ca/funded-grants/a-research-platform-to-study-animal-and-human-cellular-models-of-neurological-disordersNeurological diseases including neurodegenerative, neurodevelopmental, and psychiatric disorders are collectively one of the leading causes of disability to the Canadian population. Project Overview Neurological diseases including neurodegenerative, neurodevelopmental, and psychiatric disorders are...
-
A Ride to Remember 2020
https://braincanada.ca/about/news-updates/a-ride-to-remember-2020-2Montreal family takes life by the handlebars, and raises funds for brain research Helping to bathe and dress your grandfather is not a typical responsibility for a 17-year-old Montreal high school student. But even as teenagers, Matthew and Evan Wener were all too aware of the toll caring for a...
-
A Ride to Remember 2020
https://braincanada.ca/about/news-updates/a-ride-to-remember-2020Montreal family takes life by the handlebars, and raises funds for brain research. Helping to bathe and dress your grandfather is not a typical responsibility for a 17-year-old Montreal high school student. But even as teenagers, Matthew and Evan Wener were all too aware of the toll caring for a...
-
A sister’s love: Pushing ALS research forward
https://braincanada.ca/about/news-updates/a-sister-s-love-pushing-als-research-forwardLinda’s brother, Pierre, received an ALS diagnosis in 2017 at the age of 52 In 2017, Linda Auger Morissette’s brother, Pierre, received an amyotrophic lateral sclerosis (ALS) diagnosis at the age of 52. “This completely shocked my family,” she says. “My daughter, who views her uncle like a father,...
-
A Soccer Player Turned Brain Health Adovcate
https://braincanada.ca/about/news-updates/a-soccer-player-turned-brain-health-adovcateJay Randhawa suffered a head injury during a soccer game that ended his career. “When you face adversity and opposition, you have two choices,” he says. “Stay down and give up or get up and fight!” Jay Randhawa was – quite literally – at the top of his game before a brain injury changed everything....
-
A sustainable ecosystem of care for women with traumatic brain injury following intimate partner violence: First steps.
https://braincanada.ca/funded-grants/a-sustainable-ecosystem-of-care-for-women-with-traumatic-brain-injury-following-intimate-partner-violence-first-stepsWomen victims of intimate partner violence (IPV) are at high risk of traumatic brain injury (TBI). As many as 75% are thought to have sustained a TBI, though most remain undiagnosed and untreated, but nonetheless live with its lasting effects. Project Overview Women victims of intimate partner...
-
A Teen’s Perspective: An interview with Sydney Marconi
https://braincanada.ca/about/news-updates/a-teen-s-perspective-an-interview-with-sydney-marconiSydney Marconi is a young Métis woman from Ottawa with ancestral ties to Kapawe’no First Nation, Treaty 8. At 15, Sydney survived a car accident that left her with catastrophic brain trauma. We asked her about her experience as a young person navigating the system after a TBI. You can read her...
-
A “tipping point” neuron type driving Alzheimer’s Disease progression
https://braincanada.ca/funded-grants/a-tipping-point-neuron-type-driving-alzheimer-s-disease-progressionAlzheimer’s Disease (AD) is characterized by dysregulation of neurons involved in memory, which is believed to be caused by the production of an agent termed “amyloid beta”. Project Overview Alzheimer’s Disease (AD) is characterized by dysregulation of neurons involved in memory, which is believed...
-
A Translational Platform in CNS Drug Development
https://braincanada.ca/funded-grants/a-translational-platform-in-cns-drug-developmentTo accelerate the process of developing new drugs and treatments for CNS disorders, we propose to establish the Center for Accelerating Neuroscience Drug and Imaging Development (CANDID), a central platform that will improve the efficiency of the drug discovery process for CNS diseases in Canada by...